LEP and breast carcinoma: Aiming at the protective barrier CNN5 of the breast, as a cytokine that can inhibit tumor growth and invasion, leptin can continuously inhibit the protective effect of CCN5 by activating the JAK/AKT/STAT signaling pathway, and promote the growth and progression of breast cancer (29).